Genmab — Juli 2019
-
I livet - og i aktieinvestering.
-
Jeg har desværre ikke noget at skåle med. Er i dynerne. Vi har også åbent i familiens butik i morgen. Godnar herfra.
-
Godnat
-
17% oppe i år. Vi mangler så bare 19% op til toppen på 1.489.
-
Men, ærligt talt er faktisk kun interesseret i det langsigtede potentiale. Om vi rammer 1400 i år eller senere.. kigger faktisk kun efter om der er potentiale for kurs 2000 i 2025.. vil ikke “short term trade” mere, så mellemregningerne er mig underordnet.
-
God morgen.
-
Ny SW R&D løsning til Genmab, beklager hvis den har været linket: https://www.genedata.com/news-events/press-releases/detail/news/genedata-biopharma-platform-adopted-by-genmab-to-streamline-biotherapeutics-rd-operations/?tx_news_pi1[controller]=News&tx_news_pi1[action]=detail&cHash=42da22680d73f6678cf1fab06a2a507b
-
En god blog om CD47 target som blev købt af BliNK: https://blog.crownbio.com/cd47-sirpa-immunotherapy-target
-
Som f.eks CD20xCD47!! side 70:
https://www.rug.nl/research/portal/files/41519008/Complete_thesis.pdf -
-
Ja, også van de Donk og Usmani er inde på at en cd47-blokker kan kombineres med et cd38 antistof: Interestingly, it was recently shown that CD47 on MM cells inhibits phagocytosis induced by CD38 antibodies via ligation to SIPRα, which is expressed on phagocytes (102). Blockade of CD47-SIPRα “don't eat me” signaling may therefore increase the clinical activity of CD38 antibodies. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158369/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind